Lumateperone is a medication that was first approved by the United States Food and Drug Administration (USFDA) for the treatment of schizophrenia in adults and that later demonstrated efficacy in bipolar depression and received approval for that indication as well. This video is about the synthesis of Lumateperone.
23 сен 2024
